Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Klinger

Showing results (231-240 of 274) with videos related to

Pageof 28
Sort By:
Emergency Medicine Australasia : EMA|November 15, 2013
Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomesJeffrey A Kline, Jackeline Hernandez, Melanie M Hogg, et al.
The European Respiratory Journal|December 15, 2018
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectivesMarc Humbert, Christophe Guignabert, Sébastien Bonnet, et al.
Journal of Thrombosis and Thrombolysis|December 1, 2014
Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolismLauren K Stewart, Geoffrey W Peitz, Kristen E Nordenholz, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY): A Randomized, Double-Blind, Placebo-Controlled Crossover TrialRachel Sanders, Thomas Walsh, Grayson L Baird, et al.
Cardiovascular Research|March 17, 2016
Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in miceJason M Aliotta, Mandy Pereira, Sicheng Wen, et al.
Stem Cells Translational Medicine|May 6, 2017
Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury ModelJason M Aliotta, Mandy Pereira, Sicheng Wen, et al.
Pulmonary Circulation|June 7, 2021
Experimental design of the Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY) trialThomas P Walsh, Grayson L Baird, Michael K Atalay, et al.
American Journal of Respiratory and Critical Care Medicine|January 11, 2022
Remote 6-Minute-Walk Testing in Patients with Pulmonary Hypertension: A Pilot StudyTess LaPatra, Grayson L Baird, Randi Goodman, et al.
American Journal of Respiratory and Critical Care Medicine|May 24, 2022
Reply to Helgeson <i>et al.</i>: Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?Tess LaPatra, Grayson L Baird, Randi Goodman, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Individualized Interactomes from Pulmonary Arterial Hypertension Cell Biopsies Predict Therapeutic ResponseRui-Sheng Wang, Navneet Singh, Henri Wathieu, et al.
Pageof 28

Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
Emergency Medicine Australasia : EMA|November 15, 2013
Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomesJeffrey A Kline, Jackeline Hernandez, Melanie M Hogg, et al.
The European Respiratory Journal|December 15, 2018
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectivesMarc Humbert, Christophe Guignabert, Sébastien Bonnet, et al.
Journal of Thrombosis and Thrombolysis|December 1, 2014
Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolismLauren K Stewart, Geoffrey W Peitz, Kristen E Nordenholz, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY): A Randomized, Double-Blind, Placebo-Controlled Crossover TrialRachel Sanders, Thomas Walsh, Grayson L Baird, et al.
Cardiovascular Research|March 17, 2016
Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in miceJason M Aliotta, Mandy Pereira, Sicheng Wen, et al.
Stem Cells Translational Medicine|May 6, 2017
Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury ModelJason M Aliotta, Mandy Pereira, Sicheng Wen, et al.
Pulmonary Circulation|June 7, 2021
Experimental design of the Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY) trialThomas P Walsh, Grayson L Baird, Michael K Atalay, et al.
American Journal of Respiratory and Critical Care Medicine|January 11, 2022
Remote 6-Minute-Walk Testing in Patients with Pulmonary Hypertension: A Pilot StudyTess LaPatra, Grayson L Baird, Randi Goodman, et al.
American Journal of Respiratory and Critical Care Medicine|May 24, 2022
Reply to Helgeson <i>et al.</i>: Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?Tess LaPatra, Grayson L Baird, Randi Goodman, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Individualized Interactomes from Pulmonary Arterial Hypertension Cell Biopsies Predict Therapeutic ResponseRui-Sheng Wang, Navneet Singh, Henri Wathieu, et al.
Pageof 28